Replies to post #93210 on Anavex Life Sciences Corp (AVXL)

[Amatuer17]

It is unlikely that trial dosing has started - rett org may have identified the possible patients.

Normally all biotechs and BP announce protocol approval.

After protocol approval - trial is updated on clinicaltrials site and status is 'not recruiting'

Company then recruits the patient in the 1st site that was prepared to get protocol approved and typically there is a PR announcing this big event. Then the status of trial on site is updated with locations.

The companies use these key events to get PR mileage. So assuming that trial started and dosing started without any update is incorrect - if fact trial starting is a 8-K event.

So I am still waiting for PR onprotocol approval and trial start.

[LakeshoreLeo1953]

Do you have an idea of which CRO AVXL has engaged.

THAT likely will be the PR most seem to feel is overdue.

[scottsmith]

Material event? You don't often hear of a company burying good news.

[McMagyar]

Anavex is NOT your typical company, not your typical CEO and not your typical product..

Typically market values don't rise from
$20,000,000 to
$200,000,000 over 2 years..

Or from
200,000,000 to
20,000,000,000
Like I project for Anavex in the next
2 years...

And yes I see another 10 bagger after that!

Typically a small bio does everything able to attract anyone's attention for the next round of financing..

We agree, Anavex is anything but typical!

[attilathehunt]

Sine the Rhett Organization is involved I believe they already have the list of potential patients and have had preliminary discussions with the families. Perhaps as the families were doing their DD they became aware of the promise of A2-73 with the AD trials and even perhaps took a small stake in AVXL.